Mental Disorders

Anti-Inflammatory Diet May Lower Dementia Risk Even in People With Early Dementia Pathology

Older adults with biological signs of Alzheimer’s disease or neurodegeneration who adhered more closely to an anti-inflammatory dietary pattern had a significantly lower risk of developing dementia. In this Swedish population-based cohort study of 1,865 adults aged 60 years and older without dementia at baseline, researchers examined three healthy dietary patterns—the Alternate Mediterranean Diet (AMED), Alternative Healthy Eating Index (AHEI), and a reversed Empirical Dietary Inflammatory Index (rEDII), which reflects a diet with lower inflammatory potential. Over an average follow-up of 8.4 years, 240 participants developed dementia. Higher adherence to the anti-inflammatory rEDII pattern was associated with a 21%–29% lower dementia risk among individuals with elevated blood biomarkers linked to Alzheimer’s pathology (p-tau217), neurodegeneration (NFL), and glial activation (GFAP). In contrast, the protective associations of the Mediterranean-style and AHEI diets were observed mainly among participants with lower biomarker levels. Similar results were found for Alzheimer’s disease–related dementia. These findings suggest that reducing dietary inflammatory potential may help delay or prevent dementia not only in the general population but also in individuals who already show biological evidence of Alzheimer’s disease or other neurodegenerative processes. Source: https://jamanetwork.com/

hyangiu

Recent Posts

Intensive BP Control Reduces Cardiovascular Events After Ischemic Stroke

Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…

20 hours ago

No Significant Reduction in Major Cardiovascular Events with Intensive BP Lowering in T2D

In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…

20 hours ago

Stopping Statins Noninferior to Continuing Them in Older Adults without Known CVD

Among older adults with at least two chronic conditions but no known cardiovascular disease, discontinuing…

22 hours ago

Ziltivekimab and Pelacarsen Show No Clinical Benefit Despite Effective Biomarker Lowering

Two randomized, placebo-controlled trials of targeted therapies—ziltivekimab, a monoclonal antibody neutralizing interleukin-6, and pelacarsen, an…

2 days ago

Cold Drives Heart Failure Hospitalizations in Older US Adults

Among US Medicare beneficiaries, colder ambient temperatures were associated with increased heart failure hospitalizations while…

6 days ago

No Significant Difference Between Initial CTO-PCI and No CTO-PCI Strategies in 10-Year Follow-Up

In the 10-year extended follow-up of the DECISION-CTO trial, an initial strategy of percutaneous coronary…

6 days ago

This website uses cookies.